Allergen Immunotherapy: From Mechanisms to Biomarkers
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Stephen R. Durham , MA MD FRCP

Learning Objectives:
  1. Describe novel local and systemic responses following allergen immunotherapy
  2. Discuss how Th2A cells can be used to monitor tolerance induction during allergen immunotherapy
  3. Discuss how molecular allergology can be utilized to select patients and monitor the effects  allergen immunotherapy
10:45 AM
Mechanisms of Allergen Specific Immunotherapy: What's New?
Mohamed H. Shamji, PhD FAAAAI
11:05 AM
Question & Answer
11:10 AM
Novel Biomarkers for Monitoring AIT
William W. Kwok, PhD
11:30 AM
Question & Answer
11:35 AM
Use of Molecular Allergology to Monitor AIT: Are We There Yet?
Rudolf Valenta, MD
11:55 AM
Question & Answer
See more of: Session